Targeting Breast Cancer Cells and Their Metastases Through Luteinizing Hormone Releasing Hormone (LHRH) Receptors Using Magnetic Nanoparticles
Primary tumors and metastases from human breast cancer xenografts are specifically targeted by luteinizing hormone releasing hormone (LHRH) conjugated to superparamagnetic iron oxide nanoparticles (SPION) and incorporated into the cells. In vitro LHRH-bound magnetic nanoparticles accumulated in a 12-fold higher concentration than magnetite particles alone. In vivo, breast to lung metastases accumulated LHRH-SPION at concentrations dependent on the number of metastatic cells, while unconjugated particles did not accumulate in lung metastases.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Short Communication
Publication date: 2005-06-01
More about this publication?
- Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites